News about COVID-19

Dr. Seth Toback, Senior Vice President of Global Medical Affairs at Novavax, will present on "Local and systemic reactogenicity after mRNA and protein-based #COVID vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomised phase 2 trial (COV-BOOST)."… pic.twitter.com/nGkK1WI8jd

#BREAKING: The @WHO today recommended that #COVID19 vaccines be updated to a JN.1 strain. Novavax is committed to public health and is prepared to help. pic.twitter.com/JQbl9kJ5Yi

Scientific American: “Vaccination dramatically lowers #longCOVID risk. Several new studies reveal that getting multiple COVID vaccine doses provides strong protection against lingering symptoms.”👇 www.scientificamerican.com/article/vaccination-dramatically-lowers-long-covid-risk/

Moderna at @ESCMID 2024! 🔬🌍 We're excited to attend the #ESCMIDGlobal Congress in Barcelona, Spain. From key data and research from across our vaccine portfolio, including #COVID19, #influenza, respiratory syncytial virus, and #cytomegalovirus, we’re at the forefront of… pic.twitter.com/FrqJSYe9BR